摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,5-Bis-(trimethylsilyloxy)-6-bromo-as-triazin | 6614-55-7

中文名称
——
中文别名
——
英文名称
3,5-Bis-(trimethylsilyloxy)-6-bromo-as-triazin
英文别名
6-Brom-3,5-bis-trimethylsilyloxy-1,2,4-triazin;6-bromo-3,5-bis-trimethylsilanyloxy-[1,2,4]triazine;6-Bromo-3,5-bis[(trimethylsilyl)oxy]-1,2,4-triazine;(6-bromo-3-trimethylsilyloxy-1,2,4-triazin-5-yl)oxy-trimethylsilane
3,5-Bis-(trimethylsilyloxy)-6-bromo-as-triazin化学式
CAS
6614-55-7
化学式
C9H18BrN3O2Si2
mdl
——
分子量
336.336
InChiKey
AATYCLGQYQFKRY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.06
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    57.1
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    3,5-Bis-(trimethylsilyloxy)-6-bromo-as-triazin叔丁基锂 作用下, 以 四氢呋喃正戊烷 为溶剂, 以60%的产率得到6-trimethylsilyl-2H-1,2,4-triazine-3,5-dione
    参考文献:
    名称:
    6-氮杂嘧啶衍生物的新型环收缩
    摘要:
    在有和没有亲电子试剂的情况下,将-100氮杂嘧啶嘧啶的衍生物在-100°C下锂化。适当的6-氮杂嘧啶与叔丁基锂和二异丙基氨基锂的反应由于环收缩而得到化合物5和6。化合物5的结构不可否认地通过X射线分析确定。讨论了1,2,4-三嗪向咪唑的新型环转化的机理。
    DOI:
    10.1016/s0040-4020(00)00479-8
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Biological Activity of Some 5-Substituted-6-azauracil-N-1-Nucleosides of 2-Acetamido-2-Deoxy-D-glucose
    摘要:
    Glycosylation of the silylated 5-bromo- and 5-benzylmercapto-6-azauracil 1 and 2, respectively, with the acylated sugar 3 afforded 1-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranosyl)-5-br 4 and its 5-benzylmercapto analogue 6. Deblocking of 4 and 6 gave the free nucleosides 5 and 7, respectively. Alternatively, 6 was obtained from reaction of benzylmercaptan with 4 in pyridine. Reaction of 4 with morpholine, 2,4-dichlorobenzylamine and N-methylethanolamine gave the 5-alkylamino derivatives 8, 10 and 11, respectively. Deblocking of 8 gave nucleoside 9. All the newly synthesized compounds were characterized by their NMR, U.V. and mass specta. Compounds 5, 7, 9, 10 and 11 were tested for their activity against HIV type 1 and 2, but they did not show significant biological activity and not toxic at 100 mcg/ml. The antimutagenic activity of 5 and 7 is under investigation.
    DOI:
    10.1080/15257779508009750
点击查看最新优质反应信息

文献信息

  • Kobylinskaya, V. I.; Dashevskaya, T. A.; Shalamai, A. S., Journal of general chemistry of the USSR, 1992, vol. 62, # 5.2, p. 912 - 915
    作者:Kobylinskaya, V. I.、Dashevskaya, T. A.、Shalamai, A. S.、Levitskaya, Z. V.
    DOI:——
    日期:——
  • PURKAYASTHA, SUBHASISH;LAZREK, BIHI H.;PANZICA, RAYMOND P.;NAGUIB, FARDOS+, NUCLEOSIDES AND NUCLEOTIDES, 8,(1989) N, C. 349-356
    作者:PURKAYASTHA, SUBHASISH、LAZREK, BIHI H.、PANZICA, RAYMOND P.、NAGUIB, FARDOS+
    DOI:——
    日期:——
  • CRISTESCU, CAROL;SUPURAN, GLAUDIU, REV. ROUM. CHIM., 32,(1987) N 3, 329-333
    作者:CRISTESCU, CAROL、SUPURAN, GLAUDIU
    DOI:——
    日期:——
查看更多